retatrutide who makes it ESC 2024: improves lipid and cardiovascular risk profile in Phase II trial If retatrutide isn't FDA approved

Muizzuddin et al., 2020 In a 12-week trial on older adults with osteoarthritis, those supplementing with 6g/day of MSM experienced reduced joint pain and improved mobility, which are key metrics in aging well and preserving independence

In a nationally representative survey led by the Kinsey Institute at Indiana University, about 52% of GLP-1 users reported that the medication had impacted their sex lives, both positively and negatively

If you plan to become pregnant, talk to your clinician about when to stop the medication

For translational applications, sustained intranasal delivery aligns far closer with canonical, long-term longevity phenotypes Source: Open Access Paper: Middle-aged mice treated with GHK-Cu peptide administered intraperitoneally or intranasally show behavioral rescue but divergent hippocampal aging programs Institution: University of Washington, Seattle, WA Country: USA Journal: bioRxiv (Preprint) Impact Evaluation: The impact score of this journal is 0 (as a preprint server without a formal Clarivate index)

| 04.21.26 | 12 min read